Some specialty drugs, including those that are the most difficult to attain, are only distributed to specialty pharmacies such as PFSP Specialty Pharmacy, which are identified by pharmaceutical manufacturers as having the highest standards for clinical expertise, medication adherence, patient education, monitoring, and support.
HIV treatments have evolved greatly the past three decades with infection rates decreasing by 47% since 1998 and treatment options continuing to advance. Though efforts to find successful HIV treatments have been lengthy and, at times, presented little hope, the future is promising for new treatments, like vaccines, to make even bigger strides to irradicating HIV altogether.
When treating chronic or serious health conditions like cancer, MS, or Crohn’s disease, patients rely on the added support and access to complex medications that Specialty Pharmacies like PFSP offer. When choosing a Specialty Pharmacy, there are key factors to consider, which give patients a more successful experience and improve outcomes.
For decades, cancer has continued to be one of the leading causes of death, with almost 600,000 Americans dying of cancer every year. Currently, the most common cancer types are breast, lung, prostate, and melanoma. New trials, treatments, and research studies reveal exciting news about the battle against cancer and give hope to patients who receive a diagnosis for types of cancer that have previously been the most difficult to combat.
Studies show that specialty pharmacies are improving drug treatment outcomes and breaking down the barriers that make patient access difficult. Patients facing complex, chronic, rare, or life-threatening conditions rely on the added support and resources a specialty pharmacy provides.
Specialty Pharmacies deliver specialized care, which allows for guidance and education to help patients adhere to a treatment’s protocols. When MS treatment outcomes are compared between specialty pharmacies and community pharmacies, specialty pharmacies produce more effective treatment outcomes and fewer relapses.